Procter & Gamble vs Altria

Side-by-side comparison of AI visibility scores, market position, and capabilities

Altria leads in AI visibility (90 vs 86)

Procter & Gamble

LeaderConsumer Goods

Household Products

P&G reported $84.3B in FY2025 net sales, is navigating $1B in tariff headwinds in 2026, and has raised dividends for 69 consecutive years as a Dividend King.

AI VisibilityBeta
Overall Score
A86
Category Rank
#1 of 3
AI Consensus
64%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
88
Gemini
79

About

Procter & Gamble was founded in 1837 in Cincinnati, Ohio, where it remains headquartered, and has grown into one of the world's largest consumer goods companies with a portfolio of approximately 65 brands sold in over 180 countries. For fiscal year 2025 (ending June 2025), P&G reported net sales of $84.3 billion, with 2% organic sales growth and 4% core EPS growth. The company's five business segments are Fabric & Home Care (Tide, Dawn, Febreze), Baby, Feminine & Family Care (Pampers, Always), Beauty (Pantene, Head & Shoulders, Olay), Health Care (Oral-B, Crest, Vicks), and Grooming (Gillette, Venus).

Full profile

Altria

LeaderConsumer Goods

Enterprise

Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.

AI VisibilityBeta
Overall Score
A90
Category Rank
#83 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
97
Gemini
99

About

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.

Full profile

AI Visibility Head-to-Head

86
Overall Score
90
#1
Category Rank
#83
64
AI Consensus
58
stable
Trend
stable
94
ChatGPT
84
88
Perplexity
97
79
Gemini
99
87
Claude
86
93
Grok
87

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.